RECURSION PHARMACEUTICALS-A (RXRX)

US75629V1044 - Common Stock

9.97  -0.2 (-1.97%)

After market: 9.98 +0.01 (+0.1%)

Buy % Consensus

74

ChartMill assigns a Buy % Consensus number of 74% to RXRX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 13.26. This target is 33% above the current price.
RXRX was analyzed by 13 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about RXRX.
In the previous month the buy percentage consensus was at a similar level.
RXRX was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 9.9710.1012.7513.2617.85 - 1.30% 27.88% 33.00% 79.04%
Up and Down Grades
Date Firm Action Rating
2024-03-04 Keybanc Maintains Overweight -> Overweight
2024-02-28 Needham Maintains Buy -> Buy
2024-01-26 TD Cowen Initiate Market Perform
2024-01-17 Needham Reiterate Buy -> Buy
2024-01-16 Needham Reiterate Buy -> Buy
2023-11-13 JP Morgan Maintains Neutral -> Neutral
2023-11-09 Needham Maintains Buy -> Buy
2023-09-05 Needham Reiterate Buy -> Buy
2023-08-09 Needham Reiterate Buy -> Buy
2023-07-21 Needham Reiterate Buy -> Buy
2023-07-18 Needham Reiterate Buy -> Buy
2023-07-13 Keybanc Maintains Overweight -> Overweight
2023-07-13 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-07-12 Berenberg Reiterate Buy -> Buy
2023-07-12 Needham Reiterate Buy -> Buy
2023-05-09 Needham Reiterate Buy
2023-05-09 Keybanc Maintains Overweight
2023-04-18 Needham Reiterate Buy
2023-03-16 Needham Initiate Buy
2023-01-23 SVB Leerink Maintains Market Perform
2022-11-09 Goldman Sachs Maintains Neutral
2022-10-25 SVB Leerink Maintains Market Perform
2022-09-16 Keybanc Initiate Overweight
2022-08-11 Goldman Sachs Maintains Neutral
2022-05-24 Goldman Sachs Maintains Neutral
2022-05-12 Goldman Sachs Maintains Neutral
2022-04-18 B of A Securities Downgrade Buy -> Neutral
2022-03-04 SVB Leerink Downgrade Outperform -> Market Perform
2021-12-08 SVB Leerink Maintains Outperform
2021-09-21 Berenberg Initiate Buy